NDRG1 and pancreatic neoplasm: In fact, novel NDRG1-inducing thiosemicarbazones demonstrate pronounced activity against pancreatic cancer models in vitro and in vivo (16, 18, 34, 35, 36) and also other tumors (36, 37, 38, 39, 40, 41, 42).